Younggi Choi
Chief Scientific Officer Yuhan Corporation
Dr. Younggi Choi serves as the Deputy Chief Scientific Officer and Head of Drug Discovery at Yuhan Corporation, where he leads strategic R&D initiatives across the company’s innovative small‑molecule pipeline. With a career spanning senior scientific roles at Alkermes, FORMA Therapeutics, and Boehringer Ingelheim, he brings deep expertise in medicinal chemistry and translational drug discovery. He holds a PhD in Organic Chemistry from Oregon State University and completed postdoctoral research at The Scripps Research Institute.
Seminars
Thursday 11th June 2026
Panel Discussion: Navigating Venture Capital Funding & Structuring Strategic Collaborations in South Korea to Accelerate Biotech Growth, Secure Investment & Expand Global Reach
9:00 am
- Understanding Korean venture capital expectations to tailor fundraising strategies, attract competitive capital and enable sustainable biotech scaling
- Identifying how recent deals highlight investor priorities for emerging modalities including novel ligases, non-oncology-targeted degraders, and DACs to guide platform positioning and increase funding success
- Examining how early-stage proof-of-concept studies validate technology, strengthen investor confidence, and accelerate pharma partnership commitments
- Discussing how to structure successful biotech–pharma–academia collaborations in South Korea to balance expectations and maximize the translational speed of your TPD candidate
